1. Covalent Inhibition of HIV-1 Integrase by N-Succinimidyl Peptides.
- Author
-
Chandra K, Das P, Mamidi S, Hurevich M, Iosub-Amir A, Metanis N, Reches M, and Friedler A
- Subjects
- Dose-Response Relationship, Drug, HIV Integrase Inhibitors chemical synthesis, HIV Integrase Inhibitors chemistry, Humans, Models, Molecular, Molecular Structure, Peptides chemical synthesis, Peptides chemistry, Structure-Activity Relationship, Succinimides chemical synthesis, Succinimides chemistry, HIV Integrase metabolism, HIV Integrase Inhibitors pharmacology, Peptides pharmacology, Succinimides pharmacology
- Abstract
We present a new approach for the covalent inhibition of HIV-1 integrase (IN) by an LEDGF/p75-derived peptide modified with an N-terminal succinimide group. The covalent inhibition is mediated by direct binding of the succinimide to the amine group of a lysine residue in IN. The peptide serves as a specific recognition sequence for the target protein, while the succinimide serves as the binding moiety. The combination of a readily synthesizable peptide precursor with easy and efficient binding to the target protein makes this approach a promising new strategy for designing lead compounds., (© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2016
- Full Text
- View/download PDF